Biotech Acquisition Co - Warrants (30/11/2027) Operating Income

Biotech Acquisition Co - Warrants (30/11/2027) (BIOTW) currently reports a operating income of $-3.7M as of September 2022. That compares with $-1.1M in the prior-year period — down 243.2% year over year. Use the charts on this page to explore Biotech Acquisition Co - Warrants (30/11/2027)'s operating income history and peer comparisons.

Biotech Acquisition Co - Warrants (30/11/2027)'s operating income decreased from $-1.1M to $-3.7M — a 243.2% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biotech Acquisition Co - Warrants (30/11/2027) reported $-3.7M in operating income as of September 2022. That compares with $-1.1M in the prior-year period — down 243.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-3.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biotech Acquisition Co - Warrants (30/11/2027), and consider following BIOTW for alerts when major investors trade the stock.